🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Gummie(s) Serving Size
45 Servings
Other Combinations Product Type
40% Evidence Coverage

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Carbohydrates
4 Gram(s)
200 IU (50% DV)
✅ Within RDA (0.3× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.005mg UL 0.1mg
Calcium
200 mg (25% DV)
100 mg (13% DV)
✅ Within RDA (0.1× RDA of 700 mg) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 100mg UL 4000mg

Other Ingredients

Corn Syrup Sugar Tricalcium Phosphate Pectin Citric Acid Fumaric Acid Colors added Natural Flavors Ergocalciferol

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (98% of products) Structure/Function (89% of products) Nutrient (76% of products)

Target Groups

Children 4 or More Years of Age Adult (18 - 50 Years) Gluten Free Children more than 1 but less than 4

Product Information

📋 Directions for Use

Directions: For adults and children two years and older, chew two gummies daily. Gummy should be chewed before swallowing.

⚠️ Warnings & Precautions

Keep out of reach of children. Not for children under 2 years of age due to risk of choking. Child resistant cap. Sealed for your protection.

Do not exceed recommended dosage.

Consult a physician if you are taking any prescription medications.

🧪 Formulation Notes

Calcium with Phosphorus & Vitamin D

Excellent source of calcium Vitamin D promotes absorption Phosphorus supports bone development

Certified Gluten-Free GF

Additional Information

Natural flavors & colors Black Berry, Orange Burst, Strawberry Cream

Keep in a dry area away from direct light. Do not store product over 75(0) F.

www.spongebobvitamins.com

Gummy colors may change over time due to natural colors. This does not alter the potency of the product. Any clouding of bottle is normal.

Questions? Comments? Call 1-866-927-5470 weekdays 8:30 a.m.- 5:00 p.m. (Eastern Time)

All rights reserved.

135714-01 IVC645878

Certified Gluten-Free GF

Product Details

UPC / SKU 6 36652 90861 8
DSLD Entry Date 2016-08-24
Product Type Other Combinations
Form Gummy or Jelly
DSLD ID 64063
Data Updated 2026-04-11

Research Evidence

46 Research Sources
55 Avg Quality Score
23 Meta Analysis
7 Systematic Review
7 Rct
4 Clinical Trial
2 Other
1 Guideline
1 Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024
View all evidence for Phosphorus →

Compare Similar Products

View all Phosphorus products →